Join the 'Varicella Zoster Immune Globulin' group to help and get support from people like you.
Varicella Zoster Immune Globulin News
Posted 1 Sep 2016 by Drugs.com
THURSDAY, Sept. 1, 2016 – Chickenpox – which is caused by the varicella-zoster virus – has continued declining in the United States since 2006, when doctors began routinely recommending a second dose of chickenpox (varicella) vaccine, U.S. health officials said Thursday. States reporting vaccination data noted an 85 percent drop in the highly contagious disease between 2005-2006 and 2013-2014, according to a report from the U.S. Centers for Disease Control and Prevention. The fall-off was greatest among kids aged 5 to 14, health officials said. This is also the age group most likely to have received the second dose of varicella vaccine. Symptoms of chickenpox include an itchy, blistery rash, tiredness and fever. It tends to be more serious in babies, adults and people with a weakened immune system, the CDC noted. Before vaccination, chickenpox was commonplace, with 4 million ... Read more
Related support groups: Varicella-Zoster, Varicella Virus Vaccine, Measles Virus Vaccine/Mumps Virus Vaccine/Rubella Virus Vaccine/Varicella Virus Vaccine, ProQuad, Vaccination and Prophlaxis, Varicella Zoster Immune Globulin, Varizig, Varivax, Varicella-Zoster - Prophylaxis
Posted 21 Dec 2012 by Drugs.com
December 21, 2012 – The U.S. Food and Drug Administration has approved Varizig for reducing the severity of chicken pox (varicella zoster virus) infections in high risk individuals when given within four days after exposure. Varizig is a varicella zoster immune globulin preparation. Varicella zoster virus (VZV) causes chickenpox in children and shingles in adults. Varizig is the only FDA approved immune globulin for VZV after exposure available in the United States. It was designated as an orphan drug by the FDA and received a priority review. Most people in the United States have immunity to VZV from vaccination or from having had chickenpox during childhood. However, people without immunity to VZV who are exposed to the virus may experience severe infections that are sometimes fatal. People most at risk include children or adults with weakened immune systems, pregnant women, ... Read more